Skandinaviska Enskilda Banken (SEB)’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-155,684
| Closed | -$518K | – | 865 |
|
|
2025
Q1 | $518K | Hold |
155,684
| – | – | ﹤0.01% | 686 |
|
|
2024
Q4 | $1.11M | Buy |
155,684
+41,732
| +37% | +$299K | 0.01% | 647 |
|
|
2024
Q3 | $1.07M | Hold |
113,952
| – | – | ﹤0.01% | 662 |
|
|
2024
Q2 | $912K | Hold |
113,952
| – | – | ﹤0.01% | 649 |
|
|
2024
Q1 | $1.69M | Buy |
113,952
+17,334
| +18% | +$256K | 0.01% | 606 |
|
|
2023
Q4 | $785K | Hold |
96,618
| – | – | ﹤0.01% | 725 |
|
|
2023
Q3 | $440K | Hold |
96,618
| – | – | ﹤0.01% | 778 |
|
|
2023
Q2 | $680K | Hold |
96,618
| – | – | ﹤0.01% | 752 |
|
|
2023
Q1 | $590K | Sell |
96,618
-4,756
| -5% | -$29K | ﹤0.01% | 756 |
|
|
2022
Q4 | $648K | Sell |
101,374
-5,875
| -5% | -$37.6K | ﹤0.01% | 710 |
|
|
2022
Q3 | $1.03M | Buy |
107,249
+60,039
| +127% | +$575K | 0.01% | 676 |
|
|
2022
Q2 | $521K | Hold |
47,210
| – | – | ﹤0.01% | 801 |
|
|
2022
Q1 | $786K | Hold |
47,210
| – | – | ﹤0.01% | 784 |
|
|
2021
Q4 | $917K | Hold |
47,210
| – | – | ﹤0.01% | 781 |
|
|
2021
Q3 | $1.16M | Buy |
47,210
+24,544
| +108% | +$605K | 0.01% | 762 |
|
|
2021
Q2 | $590K | Hold |
22,666
| – | – | ﹤0.01% | 863 |
|
|
2021
Q1 | $718K | Buy |
+22,666
| New | +$718K | ﹤0.01% | 881 |
|